[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BridgeBio Pharma, Inc. Common Stock (BBIO)
BridgeBio Pharma's stock hits all-time high driven by positive Phase X results for BBP-418 and strong market performance. Investors are closely watching for potential buyouts and market trends in the biotech sector.
About BridgeBio Pharma, Inc. Common Stock
BridgeBio Pharma, Inc. Common Stock (BBIO) is a publicly traded stock in the healthcare sector focused on developing innovative medicines.
BridgeBio Pharma, Inc. Common Stock uses the ticker $BBIO for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- BridgeBio Pharma, Inc. Common Stock (BBIO) trading volume is up XXXXX% from the previous week.
- BridgeBio Pharma, Inc. Common Stock (BBIO) sentiment is up XXXXX% from the previous week.
- BridgeBio Pharma, Inc. Common Stock (BBIO) creators is up XXXXX% from the previous week.
Price: $XXXXX
Price 24-Hour Time-Series Raw Data
The stock price has surged to a 52-week and all-time high, driven by highly positive Phase X results for BBP-418, strong overall market performance, and increased market cap, indicating robust investor confidence. Social sentiment and mentions of BBIO as a top performer in various analyses support this upward trend.
24-Hour: XXXX% 7-Day: -XXXX% 30-Day: XXXXX%
1-Year High: $XXXXX on 2025-12-04
1-Year Low: $XX on 2024-12-18
AltRank: XXX
AltRank 24-Hour Time-Series Raw Data
BridgeBio Pharma, Inc. Common Stock (BBIO) is currently AltRank #851 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX +293
X Month: XXX -XXX
X Months: XXX +329
X Year: XXX +267
1-Year High: XXXXX on 2025-09-25
1-Year Low: XX on 2025-02-23
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX -XX
X Months: XX +9
X Year: XX +18
1-Year High: XX on 2025-02-04
1-Year Low: XX on 2024-12-19
Engagements: XXXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
X Week: XXXXXX +0.16%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXXX +21%
1-Year High: XXXXXXX on 2025-02-20
1-Year Low: XXXXX on 2025-10-18
Engagements by network (24h): Reddit: X TikTok: X X: XXXXXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX +1.20%
X Month: XXX -XX%
X Months: XXXXX +32%
X Year: XXXXX +77%
1-Year High: XXX on 2024-12-15
1-Year Low: XX on 2025-12-07
Mentions by network (24h): Reddit: X TikTok: X X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning BridgeBio Pharma, Inc. Common Stock (BBIO) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XXX +16%
X Month: XXX -XXXX%
X Months: XXXXX +134%
X Year: XXXXX +106%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2025-09-15
The most influential creators that mention BridgeBio Pharma, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Andre_AGTC | X | XXXXX | X | XXX |
| @BiopharmIQ | X | XXXXXX | X | XXX |
| @semodough | X | XXXXXX | X | XX |
| @NightOwlBiotech | X | XXXXX | X | XX |
| @altivolans | X | XX | X | XX |
| @seedytx19 | X | XXXXX | X | XX |
| @ParadiseTraderr | X | XXX | X | XX |
| @BigChodu | X | XXXXX | X | XX |
| @Bio_youtuber | X | XXXXX | X | XX |
| @SteveDJacobs | XX | XXXXX | X | X |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +25%
X Month: XX% -X%
X Months: XX% +2%
X Year: XX% +17%
1-Year High: XX% on 2025-11-13
1-Year Low: XX% on 2025-04-19
Most Supportive Themes:
- Positive Phase X Results for BBP-418: (50%) BridgeBio Pharma's drug for a muscle disorder, BBP-418, met its goals in a late-stage trial, leading to positive sentiment and stock price surges.
- Strong Market Performance and Increased Market Cap: (30%) The stock's price action is also attributed to the overall strong market performance and a significant increase in market capitalization.
Most Critical Themes:
- FDA Hold on Intellia Therapeutics: (10%) While not directly about BBIO, news of an FDA hold on a competitor like Intellia Therapeutics can impact overall biotech sentiment and investor focus.
- Debt and Cash Burn: (10%) Some posts mention the company's debt and cash burn, which could be a point of concern for investors despite positive trial results.
Social Dominance: XXXXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
X Week: XXXXX% -XXXXX%
X Month: XXXXX% +0.0021%
X Months: XXXXX% +0.0023%
X Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2024-12-15
1-Year Low: XXXXXX% on 2025-10-12
Market Dominance: XXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXX% on 2025-12-02
1-Year Low: XXXXXXX% on 2025-03-11
Market Cap: $XXXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXX -$1.20%
X Month: $XXXXXXXXXXXXXX +$11%
X Months: $XXXXXXXXXXXXXX +$89%
X Year: $XXXXXXXXXXXXXX +$160%
1-Year High: $XXXXXXXXXXXXXX on 2025-12-04
1-Year Low: $XXXXXXXXXXXXX on 2024-12-18
Top BridgeBio Pharma, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"+Initiations 12/11:$ANF $APO $BBIO $BOOT $CG $CGON $CHYM $FOUR $GCTS $GRRR $HLNE $IKT $IONQ $JEF $KKR $OPAD $OVID $QBTS $RGTI $SCHW $SF $SUPV $TPG $TRIN . -Initiations 12/11: $CRI"
X Link @OpenOutcrier 2025-12-11T14:02Z 79.9K followers, 1614 engagements
"🔹BridgeBio Pharma $BBIO Outperform by Bernstein Target $XX 📉Top X Defensive #Stocks To Dump This Quarter: Benzinga 🔹Spectrum Brands Holdings Inc $SPB overbought RSI XXXX Q4 adj EPS beat halted China imports amid trade risk stock +19% MoM 52W H $XXXXX #StockTips"
X Link @boominance 2025-12-11T13:48Z XXX followers, XX engagements
"Bernstein🏁 $BBIO at an Outperform-$94 and said 'Ample Upside Even if Attruby Hits Choppy Seas. Initiate at Outperform $XX PT' $ALNY $PFE AZN BAYRY BMRN ASND Bernstein additionally said in its BridgeBio initiation report: We believe expectations for ATTR-CM drug Attruby are reasonable near/mid-term and arguably too high long term while we see upside to consensus numbers for infigratinib and encaleret. We are in line for BBP-418. Key proprietary analyses in this initiation: ATTR-CM doc survey infigratinib doc feedback infigratinib Ph3 trial analysis. Our survey of N=30 ATTR docs was less"
X Link @Quantumup1 2025-12-11T11:13Z 3926 followers, 1431 engagements
"TOP XX FAVORITE NAMES TRADING UNDER $XX X. $ONDS Ondas X. $NVTS Navitas X. $PRME Prime X. $ACHR Archer X. $PSNL Personalis X. $GRAB Grab X. $OPEN Opendoor X. $ENVX Enovix X. $RR Richtech XX. $INDI indie $VRTX $AMGN $INCY $BHVN $BBIO $ECL $SHW $MOS $FMC $IP $APD $WRK $NUE $IFF"
X Link @SMALLCAPSAXIS 2025-12-10T20:01Z XXX followers, 1243 engagements